On May 10-12, 2019, the fifth annual meeting of reproductive medicine sponsored by reproductive medicine professional committee of Chinese medical doctor association was successfully held in Fuzhou Strait International Convention and Exhibition Center.
The conference was very lively. It brought together experts and scholars from all provinces and cities in China to share the new knowledge, experience and current research progress of reproductive medicine. At the same time, it also put forward the problems and opinions that we met together. It is a rare opportunity to exchange and learn from each other. It not only improves the knowledge of reproductive medicine, but also has a new understanding of the concept of reproduction. The annual reproductive conference provides a platform for all of you to learn from each other.
Unimed Biotech (Shanghai) Co., Ltd. has launched its products in the field of reproductive genetics. Our products cover pre pregnancy, preimplantation, prenatal, abortion and newborn. We are committed to providing overall solutions for reproductive genetics. In the field of preimplantation testing (PGT), Unimed has two star products. One is uniseq ® PGT-A, a preimplantation aneuploidy detection scheme based on high-throughput sequencing (NGS) technology, independently developed by hotronics. The other is karyomapping technology based on the whole genome SNP chip of Illumina, which can realize the detection of chromosome balanced translocation, Roche translocation, single gene genetic disease, HLA matching and aneuploidy. In our booth, a large number of participants came to exchange consultation, discuss enthusiastically and deepen cooperation.
And Unimed as always strives to forge ahead, continues to expand the scope of business, improve the competitiveness of products and services. Now the company's team is growing and its performance keeps a strong momentum of growth. We believe that Unimed will do better and contribute a little to the development of the field of human assisted reproduction. At the same time, we look forward to the appointment of Haikou in 2020.